Pharmaceutical Manufacturing News
CordenPharma Inaugurates Increased Peptide Production of the Largest Worldwide SPPS Manufacturing Plant
CordenPharma announces the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide. Read more
18 Sep 2023
Pharma Manufacturing News + Pharmaceutical Manufacturing News
NHS World First Rollout Of Cancer Jab Cuts Treatment Time By Up To 75%
Following the green light from the Medicines and Healthcare products Regulatory Agency (MHRA), the NHS in England will be the first health system in the world to roll out the seven-minute injection to hundreds of patients each year. Read more
30 Aug 2023
Statements by CMS Leadership on First Selected Drugs for Medicare Drug Price Negotiation
For the first time, Medicare is able to directly negotiate the prices of prescription drugs due to President Biden’s lower cost prescription drug law, the Inflation Reduction Act. Read more
29 Aug 2023
Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations Launch The Meningitis Flag
The Meningitis Research Foundation, the Confederation of Meningitis Organisations (CoMO) and Sanofi join forces to launch ‘The Meningitis Flag’, a global initiative to raise awareness in the fight against meningitis. Read more
29 Aug 2023
Bio-Rad Launches First StarBright Red Dye
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, have announced the launch of the 29th StarBright Dye, StarBright Red 670. Read more
29 Aug 2023
Graham Armitage Appointed Managing Director at EIT Health Ireland-UK
EIT Health Ireland-UK, a Co-location Centre of EITHealth, which is part of the European Institute of Innovation and Technology, a body of the European Union, have announced that Graham Armitage has been appointed as Managing Director. Read more
29 Aug 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Safeguarding Brands and Patients: Layered Anti-Counterfeiting Measures in Packaging Design
David Gonzalez, Technical Account Manager, MM Packaging discusses ways of safeguarding brands and patients against counterfeit measures prominent in the world of pharma. Read more
27 Sep 2023
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Optimising Biopharmaceutical Production with Pre-packed Process-Scale Chromatography Columns
The adoption and implementation of pre-packed process-scale chromatography columns has emerged as a promising solution to improving overall processing efficiency while maintaining high levels of quality and reducing costs. Read more
21 Jun 2023
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Orchard Therapeutics Receives FDA Approval of Lenmeldy
Orchard Therapeutics, recently acquired by Kyowa Kirin, have announced the U.S. FDA has approved Lenmeldy for the treatment of children with early-onset—metachromatic leukodystrophy. Read more
19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca
Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, have announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bluebird Bio Secures up to $175 Million Debt Financing
Bluebird Bio has entered into a $175 million five-year, term loan facility with Hercules Capital. The transaction strengthens the Company’s balance sheet as it executes on the commercial launches for its three FDA approved gene therapies. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
ReciBioPharm and GeneVentiv Therapeutics to Partner
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia. Read more
18 Mar 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25